MedTrace Logo

Zurich Disability Prevention Trial

NCT01017354 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2015-08-24

No results posted yet for this study

Summary

This project was designed to optimizing vitamin D status in prefrail seniors age 70+ living at home and prevent their functional decline. We test 3 arms of monthly vitamin D supplementation. Intermittent dosing will improve adherence and simplify vitamin D supplementation.

Conditions

  • Community-dwelling Seniors
  • History of a Fall in the Previous 12 Months

Interventions

DRUG

Hidroferol® (ES)

24000 IU vitamin D3 orally and once per month plus 300 mcg 25(OH)D orally and once per month

DIETARY_SUPPLEMENT

ViDe3 (CH)

60000 vitamin D3 orally and once per month

DIETARY_SUPPLEMENT

ViDe3 (CH)

24000 Vitamin D3 orally and once per month

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Heike Bischoff Ferrari, MD, MPH · University Hospital Zurich, Centre on Aging and Mobility

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-11-30
Completion
2011-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01017354 on ClinicalTrials.gov